Veru Inc. (VERU) is a publicly traded Healthcare sector company. As of July 27, 2026, VERU trades at $2.31 with a market cap of $36.11M and a P/E ratio of -2.88. VERU moved +4.67% today. Year to date, VERU is +3.69%; over the trailing twelve months it is -62.50%. Its 52-week range spans $2.05 to $14.20. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces VERU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for VERU, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.31 |
| Market Cap | $36.11M |
| P/E Ratio | -2.88 |
| EPS | $-0.78 |
| Dividend Yield | 0.07% |
| 52-Week High | $14.20 |
| 52-Week Low | $2.05 |
| Volume | 33.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $9.11M |
| Net Income | $-6.91M |
| Gross Margin | 0.00% |
1 analysts cover VERU: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.